COVID-19 Preparedness Press Briefing | January 31, 2022 | UPMC

UPMCclinical leaders provide an update on the impact of the Omicron variant nd provide more information about Evusheld— the first-ever monoclonal antibody cocktail authorized by the FDA for the prevention of COVID-19 prior to an exposure— which we give to patients with immune-compromising conditions. To learn more, please visit https://www.upmc.com/coronavirus